Alphatec Holdings, Inc. (NASDAQ:ATEC) Shares Sold by Geode Capital Management LLC

Geode Capital Management LLC decreased its stake in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) by 1.5% during the third quarter, HoldingsChannel reports. The firm owned 2,362,879 shares of the medical technology company’s stock after selling 34,906 shares during the quarter. Geode Capital Management LLC’s holdings in Alphatec were worth $13,140,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Point72 Asset Management L.P. grew its holdings in shares of Alphatec by 65.2% during the second quarter. Point72 Asset Management L.P. now owns 3,192,789 shares of the medical technology company’s stock valued at $33,365,000 after buying an additional 1,260,137 shares during the last quarter. State Street Corp grew its stake in Alphatec by 10.1% during the 3rd quarter. State Street Corp now owns 3,138,960 shares of the medical technology company’s stock valued at $17,453,000 after purchasing an additional 287,350 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its holdings in shares of Alphatec by 11.3% in the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 2,928,094 shares of the medical technology company’s stock valued at $16,280,000 after purchasing an additional 297,850 shares during the period. Fred Alger Management LLC raised its stake in shares of Alphatec by 0.8% in the second quarter. Fred Alger Management LLC now owns 2,638,303 shares of the medical technology company’s stock worth $27,570,000 after purchasing an additional 21,078 shares during the last quarter. Finally, First Turn Management LLC lifted its holdings in shares of Alphatec by 37.3% during the second quarter. First Turn Management LLC now owns 1,360,410 shares of the medical technology company’s stock worth $14,216,000 after purchasing an additional 369,792 shares during the period. Hedge funds and other institutional investors own 66.35% of the company’s stock.

Alphatec Price Performance

NASDAQ:ATEC opened at $9.08 on Tuesday. The stock has a market capitalization of $1.29 billion, a PE ratio of -7.09 and a beta of 1.38. Alphatec Holdings, Inc. has a 52 week low of $4.88 and a 52 week high of $17.34. The company has a quick ratio of 1.15, a current ratio of 2.32 and a debt-to-equity ratio of 30.21. The stock’s 50-day moving average price is $8.81 and its 200-day moving average price is $8.05.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on ATEC shares. HC Wainwright reissued a “buy” rating and set a $20.00 price target on shares of Alphatec in a research report on Thursday, October 31st. Needham & Company LLC reissued a “buy” rating and set a $13.00 target price on shares of Alphatec in a report on Thursday, October 31st. Barclays boosted their target price on shares of Alphatec from $19.00 to $20.00 and gave the company an “overweight” rating in a research report on Tuesday, November 19th. Finally, Lake Street Capital reduced their price objective on Alphatec from $32.00 to $18.00 and set a “buy” rating for the company in a research note on Tuesday, September 3rd. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $17.11.

Alphatec Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.